Morgan Stanley’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12M Sell
183,115
-28,869
-14% -$1.89M ﹤0.01% 3278
2025
Q1
$15M Sell
211,984
-168,637
-44% -$11.9M ﹤0.01% 2979
2024
Q4
$25M Buy
380,621
+153,537
+68% +$10.1M ﹤0.01% 2546
2024
Q3
$16M Sell
227,084
-16,410
-7% -$1.16M ﹤0.01% 3013
2024
Q2
$16.1M Sell
243,494
-108,933
-31% -$7.22M ﹤0.01% 2895
2024
Q1
$23.9M Sell
352,427
-764,761
-68% -$51.9M ﹤0.01% 2505
2023
Q4
$69M Buy
1,117,188
+949,482
+566% +$58.7M ﹤0.01% 2114
2023
Q3
$9.89M Buy
167,706
+1,590
+1% +$93.8K ﹤0.01% 3137
2023
Q2
$9.92M Sell
166,116
-51,897
-24% -$3.1M ﹤0.01% 3176
2023
Q1
$12.7M Sell
218,013
-29,118
-12% -$1.7M ﹤0.01% 2904
2022
Q4
$15.3M Buy
247,131
+65,688
+36% +$4.08M ﹤0.01% 2603
2022
Q3
$10.3M Sell
181,443
-25,803
-12% -$1.46M ﹤0.01% 2959
2022
Q2
$13.2M Buy
207,246
+81,921
+65% +$5.23M ﹤0.01% 2754
2022
Q1
$8.12M Sell
125,325
-18,663
-13% -$1.21M ﹤0.01% 3155
2021
Q4
$9.58M Buy
143,988
+1,632
+1% +$109K ﹤0.01% 2993
2021
Q3
$8.69M Buy
142,356
+5,568
+4% +$340K ﹤0.01% 3058
2021
Q2
$8.47M Buy
136,788
+10,185
+8% +$631K ﹤0.01% 3178
2021
Q1
$7.5M Sell
126,603
-5,913
-4% -$350K ﹤0.01% 2967
2020
Q4
$7.93M Buy
132,516
+1,569
+1% +$93.8K ﹤0.01% 2760
2020
Q3
$7.14M Sell
130,947
-2,358
-2% -$129K ﹤0.01% 2354
2020
Q2
$6.84M Buy
133,305
+2,556
+2% +$131K ﹤0.01% 2340
2020
Q1
$5.87M Sell
130,749
-19,083
-13% -$856K ﹤0.01% 2300
2019
Q4
$8M Sell
149,832
-2,277
-1% -$122K ﹤0.01% 2671
2019
Q3
$7.09M Sell
152,109
-33,678
-18% -$1.57M ﹤0.01% 2489
2019
Q2
$9.34M Sell
185,787
-26,613
-13% -$1.34M ﹤0.01% 2234
2019
Q1
$10.9M Sell
212,400
-18,936
-8% -$972K ﹤0.01% 1958
2018
Q4
$10.9M Sell
231,336
-670,047
-74% -$31.4M ﹤0.01% 2040
2018
Q3
$50.4M Buy
901,383
+16,068
+2% +$899K 0.01% 954
2018
Q2
$44.7M Buy
885,315
+40,542
+5% +$2.05M 0.01% 984
2018
Q1
$41.5M Buy
844,773
+57,972
+7% +$2.85M 0.01% 1032
2017
Q4
$40.5M Sell
786,801
-63,153
-7% -$3.25M 0.01% 1094
2017
Q3
$44.3M Buy
849,954
+180,213
+27% +$9.39M 0.01% 979
2017
Q2
$34.6M Buy
669,741
+264,588
+65% +$13.7M 0.01% 1122
2017
Q1
$20.4M Sell
405,153
-132,999
-25% -$6.69M 0.01% 1545
2016
Q4
$25.4M Buy
538,152
+201,180
+60% +$9.48M 0.01% 1331
2016
Q3
$16.8M Sell
336,972
-307,257
-48% -$15.3M 0.01% 1596
2016
Q2
$31M Buy
644,229
+216,627
+51% +$10.4M 0.01% 1096
2016
Q1
$19.5M Sell
427,602
-472,770
-53% -$21.6M 0.01% 1322
2015
Q4
$48.5M Buy
900,372
+80,046
+10% +$4.31M 0.02% 800
2015
Q3
$40.5M Sell
820,326
-345,465
-30% -$17M 0.02% 914
2015
Q2
$67.9M Buy
1,165,791
+29,538
+3% +$1.72M 0.02% 703
2015
Q1
$65.3M Buy
1,136,253
+320,808
+39% +$18.4M 0.02% 695
2014
Q4
$41.2M Sell
815,445
-16,614
-2% -$838K 0.02% 962
2014
Q3
$38.9M Sell
832,059
-4,260
-0.5% -$199K 0.02% 958
2014
Q2
$37.7M Sell
836,319
-43,233
-5% -$1.95M 0.01% 963
2014
Q1
$37.1M Buy
879,552
+25,266
+3% +$1.07M 0.02% 920
2013
Q4
$33.6M Sell
854,286
-23,367
-3% -$920K 0.01% 969
2013
Q3
$31.1M Buy
877,653
+23,799
+3% +$844K 0.01% 932
2013
Q2
$28.4M Buy
+853,854
New +$28.4M 0.01% 937